Ignite Creation Date:
2024-05-06 @ 7:20 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05976347
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2023-07-28
Brief Title:
Identifying and Treating Depression in the Orthopaedic Trauma Population
Sponsor:
Wake Forest University Health Sciences
Organization:
Wake Forest University Health Sciences
Study Overview
Official Title:
Identifying and Treating Depression in the Orthopaedic Trauma Population
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this trial is to pilot a way for orthopaedic surgeons to safely screen for depression and provide treatment for depression with medication The main questions it aims to answer are
1 What are the outcomes of patients who screen positive for depressive symptoms and are prescribed either an Selective serotonin reuptake inhibitors SSRI or serotonin and norepinephrine reuptake inhibitors SNRI
2 What are the outcomes of patients who screen positive for depressive symptoms and choose not to pursue treatment with medication
1 What are the outcomes of patients who screen positive for depressive symptoms and are prescribed either an Selective serotonin reuptake inhibitors SSRI or serotonin and norepinephrine reuptake inhibitors SNRI
2 What are the outcomes of patients who screen positive for depressive symptoms and choose not to pursue treatment with medication
Detailed Description:
Depression is common among orthopaedic trauma patients and associated with worsened outcomes including pain opioid consumption patient-reported outcomes complications and length of stay Addressing depression therefore should lead to improved outcomes Orthopaedic surgeons may believe treating depression is outside their scope or that they lack tools to address depressive symptoms In fact only 45 of surgeons report they are likely to screen patients and only 27 are likely to refer patients for psychological treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MSKRSH040123 | OTHER | Atrium Health | None |